High-frequency spinal cord stimulation for herpes zoster pain relief
Official title: The Efficacy of High-frequency Short-time Spinal Cord Stimulation in the Treatment of Herpes Zoster-associated Neuralgia
Run by Zunyi Medical College · NCT06942806 · Data updated 2026-11-12
This study is testing if high-frequency spinal cord stimulation can help relieve pain for people with shingles who haven't found relief from regular treatments.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 40 Years to 85 Years |
| Sex | All |
| Enrollment | 74 (estimated) |
| Sponsor | Zunyi Medical College Academic / other |
| Locations | 1 site (Zunyi, Guizhou) |
| Status | Recruiting |
| Started | February 1, 2024 |
| Main results expected | May 31, 2025 |
| Study ends | May 31, 2025 |
| Registry record updated | April 30, 2025 |
| Trial ID | NCT06942806 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include patients with moderate to severe herpes zoster-associated pain who have not responded to non-surgical treatments.
✕Probably not a fit
Patients with severe psychiatric disorders or those with significant local or systemic infections may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the effectiveness of high-frequency spinal cord stimulation (HF-SCS) in treating herpes zoster-associated neuralgia, a painful condition resulting from the reactivation of the varicella-zoster virus. The research focuses on patients who have not responded adequately to conventional treatments and examines the impact of HF-SCS on pain relief and quality of life. The methodology involves comparing HF-SCS with traditional low-frequency stimulation, assessing various parameters such as frequency, pulse width, and amplitude to optimize pain management. The study aims to provide insights into the mechanisms of pain modulation and the potential benefits of HF-SCS in this patient population.
Why it matters
Potential benefit: If successful, this approach could significantly improve pain management and quality of life for patients suffering from herpes zoster-associated neuralgia.
How similar studies have gone: Previous studies have shown promising results with spinal cord stimulation for neuropathic pain, suggesting potential success for this novel high-frequency approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Patients with inadequate response to non-surgical treatments such as pharmacotherapy; 2. Patients with major organ dysfunction intolerant to drug therapy; 3. Patients with systemic comorbidities (e.g., hypertension, diabetes mellitus); 4. Patients with moderate to severe pain intensity (Numerical Rating Scale \[NRS\] score ≥ 4). Exclusion Criteria: 1. Patients with severe psychiatric disorders; 2. Patients with severe local or systemic infections at the puncture site; 3. Patients with severe coagulopathies (platelet count \< 80×10⁹/L during puncture) or those requiring uninterrupted anticoagulation therapy without bridging protocol; 4. Patients with end-stage organ failure who cannot maintain prone positioning or tolerate the procedure; 5. Patients with severe spinal stenosis, vertebral ankylosis, or scoliosis; 6. Patients with language barrier or impaired communication abilities.ion
Where it's running
-
149 Dalian Road, Huichuan District, Zunyi City, Guizhou Province
Zunyi, Guizhou, China Recruiting
Study contacts
- Study coordinator: 梨 赵
- Email: 1287802477@qq.com
- Phone: +8615285410762
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Combining high-voltage pulsed radiofrequency with liposomal bupivacaine for treating herpes zoster pain
This study is testing if a combination of a special type of radiofrequency treatment and a pain relief injection can help people aged 40 to 85 who have severe pain from shingles feel better when other treatments haven't worked.
-
Treatment for Herpes Zoster Pain Using Dexmedetomidine and High Voltage Therapy
This study is testing whether a nasal spray with dexmedetomidine, used alongside high-voltage therapy, can help people with painful herpes zoster feel better.
-
Genotype-guided selection of P2Y12 inhibitors after complex heart procedures
This study is testing if choosing heart medication based on a person's genes can help people with acute coronary syndrome feel better after complex heart procedures while reducing side effects.
-
Using Rivaroxaban to Prevent Thrombus After Heart Attack
This study tests if adding a low dose of rivaroxaban to standard heart medications can help prevent blood clots in patients who have just had a heart attack.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.